Trial Profile
Comparison of lipid lowering effect of anagliptin and miglitol in patients with type 2 diabetes
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 01 Apr 2019
Price :
$35
*
At a glance
- Drugs Anagliptin (Primary) ; Miglitol (Primary)
- Indications Type 2 diabetes mellitus
- Focus Pharmacodynamics
- 27 Mar 2019 Status changed from recruiting to completed.
- 26 May 2016 New trial record